Embolization Particle Market Research Report: Information By Product Type (Radioembolization and Drug Eluting Beads), By Application (Oncology, Peripheral Vascular Disease, Neurology), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 Report Prologue

2 Market Introduction

2.1 Definition 15

2.2 Scope Of The Study 15

2.2.1 Research Objective 15

2.2.2 Assumptions 15

2.2.3 Limitations 16

3 Research Methodology

3.1 Primary Research Methodology 18

3.2 Secondary Research Methodology 19

3.3 Market Size Estimation 20

3.4 Market Share Analysis 22

3.5 Trade Analysis 22

3.6 Market Pricing Approach 22

4 Market Dynamics

4.1 Introduction 23

4.2 Driver 24

4.2.1 Growing Demand Of Embolization Particles For Interventional Radiology And Interventional Cardiovascular Procedure (Impact Weightage- 35%) 24

4.2.2 Embolization Is Best Minimally Invasive Alternatives Available For The

Interventional Procedures (Impact Weightage- 30%) 25

4.2.3 Increasing Prevalence Of Various Types Of Cancer Is One Of The Major Factor Responsible For Market Growth (Impact Weightage- 25%) 26

4.2.4 Favourable Reimbursement Scenario (Impact Weightage- 10%) 27

4.3 Restraints 28

4.3.1 Less Number Of Interventional Neuroradiologists And Interventional

Neuroradiology (INR) Labs (Impact Weightage- 40%) 28

4.3.2 Strict Regulatory Rules (Impact Weightage-60% 29

4.4 Opportunities 30

4.4.1 Recent Advances In Microsphere Technologies 30

4.5 Mega Trends 30

4.6 Macroeconomic Indicators 31

5 Market Factor Analysis

5.1 Porter's 5 Forces Analysis 32

5.1.1 Bargaining Power Of Suppliers 33

5.1.2 Bargaining Power Of Buyers 33

5.1.3 Threat Of New Entrants 33

5.1.4 Threat Of Substitutes 33

5.1.5 Intensity Of Rivalry 33

5.2 Value Chain Analysis 34

5.2.1 R&D 34

5.2.2 Clinical Test & Legal Issues 35

5.2.3 Manufacturing 35

5.2.4 Marketing & Sales 35

5.3 Purchasing Activities, Strategies And Implications 36

5.4 Investment Opportunity Analysis 36

5.5 Pricing Impact Of Embolization Particle (Lipiodol): Effects & Implications 37

5.6 Reimbursement Issues In Embolization Procedures 38

6 Global Embolization Particle Market, By Product Type

6.1 Introduction 40

6.2 Radioembolization Spheres 41

6.3 Drug Eluting Beads 42

7 Global Embolization Particle Market, By Application

7.1 Introduction 43

7.2 Oncology 45

7.3 Urology 46

7.4 Peripheral Vascular Disease 47

7.5 Neurology 48

8 Global Embolization Particle Market, By Level Of Occlusion

8.1 Introduction 49

8.1.1 Proximal 50

8.1.2 Distal 50

9 Global Embolization Particle Market, By End User

9.1 Introduction 51

9.2 Hospitals & Clinics 52

9.3 Ambulatory Centers 53

10 Global Embolization Particle Market, By Region

10.1 Introduction 54

10.2 Americas 56

10.2.1 U.S. 59

10.2.2 Canada 61

10.2.3 South America 63

10.3 Europe 66

10.3.1 Germany 69

10.3.2 France 71

10.3.3 UK 73

10.3.4 Italy 75

10.3.5 Spain 77

10.3.6 Rest Of Europe 79

10.4 Asia Pacific 82

10.4.1 Japan 85

10.4.2 China 87

10.4.3 India 89

10.4.4 Republic Of Korea 91

10.4.5 Australia 93

10.4.6 Rest Of Asia Pacific 95

10.4.7 Middle East & Africa 97

11 Competitive Landscape

11.1 Introduction 100

11.2 Company Share Analysis 101

12 Company Profiles

12.1 Boston Scientific Corporation 102

12.1.1 Company Overview 102

12.1.2 Financials 102

12.1.3 Products 102

12.1.4 Strategy 102

12.1.5 Key Developments 102

12.2 Guerbet 103

12.2.1 Company Overview 103

12.2.2 Financials 103

12.2.3 Products 103

12.2.4 Strategy 103

12.2.5 Key Developments 103

12.3 BTG International Ltd 104

12.3.1 Company Overview 104

12.3.2 Financials 104

12.3.3 Products 104

12.3.4 Strategy 104

12.3.5 Key Developments 104

12.4 Medtronics 105

12.4.1 Company Overview 105

12.4.2 Financials 105

12.4.3 Products 105

12.4.4 Strategy 105

12.4.5 Key Developments 105

12.5 Sirtex 106

12.5.1 Company Overview 106

12.5.2 Financials 106

12.5.3 Products 106

12.5.4 Strategy 106

12.5.5 Key Developments 106

12.6 Terumo 107

12.6.1 Company Overview 107

12.6.2 Financials 107

12.6.3 Products 107

12.6.4 Strategy 107

12.6.5 Key Developments 107

12.7 Merit Medical 108

12.7.1 Company Overview 108

12.7.2 Financials 108

12.7.3 Products 108

12.7.4 Strategy 108

12.7.5 Key Developments 108

13 MRFR Conclusion

13.1 Key Findings 109

13.1.1 From CEO’s View Point 109

13.1.2 Unmet Needs 109

13.2 Key Companies To Watch 109

14 Appendix

14.1 Discussion Blue Print 110

14.2 References 112

15 List Of Tables

TABLE 1 PRIMARY INTERVIEWS 18

TABLE 2 SAMPLE SIZE DETERMINATION OF END-USERS (HOSPITALS, CLINICS) 19

TABLE 3 AVERAGE PRICING OF LIPIODOL IN VARIOUS COUNTRIES (USD) 38

TABLE 4 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 40

TABLE 5 GLOBAL EMBOLIZATION PARTICLE MARKET FOR RADIOEMBOLIZATION SPHERES, BY REGION,

2020-2027 (USD MILLION) 41

TABLE 6 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DRUG ELUTING BEADS, BY REGION,

2020-2027 (USD MILLION) 42

TABLE 7 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 43

TABLE 8 GLOBAL EMBOLIZATION PARTICLE MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 9 GLOBAL EMBOLIZATION PARTICLE MARKET FOR UROLOGY, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 10 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PERIPHERAL VASCULAR DISEASE, BY REGION,

2020-2027 (USD MILLION) 47

TABLE 11 GLOBAL EMBOLIZATION PARTICLE MARKET FOR NEUROLOGY, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 49

TABLE 13 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PROXIMAL, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 14 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DISTAL, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 15 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 51

TABLE 16 GLOBAL EMBOLIZATION PARTICLE MARKET FOR HOSPITALS & CLINICS, BY REGION,

2020-2027 (USD MILLION) 52

TABLE 17 GLOBAL EMBOLIZATION PARTICLE MARKET FOR AMBULATORY CENTERS, BY REGION,

2020-2027 (USD MILLION) 53

TABLE 18 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 19 AMERICAS EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 & 2027 (USD MILLION) 56

TABLE 20 AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 57

TABLE 21 AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 58

TABLE 22 AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 58

TABLE 23 AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 59

TABLE 24 U.S. EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 59

TABLE 25 U.S. EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 60

TABLE 26 U.S. EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 60

TABLE 27 U.S. EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 61

TABLE 28 CANADA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 61

TABLE 29 CANADA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 62

TABLE 30 CANADA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 62

TABLE 31 CANADA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 63

TABLE 32 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 63

TABLE 33 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64

TABLE 34 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

2020-2027 (USD MILLION) 64

TABLE 35 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 65

TABLE 36 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 66

TABLE 37 EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 67

TABLE 38 EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68

TABLE 39 EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 68

TABLE 40 EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 69

TABLE 41 GERMANY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 69

TABLE 42 GERMANY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70

TABLE 43 GERMANY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 70

TABLE 44 GERMANY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 71

TABLE 45 FRANCE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 71

TABLE 46 FRANCE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 72

TABLE 47 FRANCE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 72

TABLE 48 FRANCE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 73

TABLE 49 UK EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 73

TABLE 50 UK EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74

TABLE 51 UK EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 74

TABLE 52 UK EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 75

TABLE 53 ITALY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 75

TABLE 54 ITALY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76

TABLE 55 ITALY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 76

TABLE 56 ITALY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 77

TABLE 57 SPAIN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 77

TABLE 58 SPAIN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78

TABLE 59 SPAIN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 78

TABLE 60 SPAIN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 79

TABLE 61 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 79

TABLE 62 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80

TABLE 63 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

2020-2027 (USD MILLION) 80

TABLE 64 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 81

TABLE 65 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 82

TABLE 66 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 83

TABLE 67 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84

TABLE 68 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 84

TABLE 69 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 85

TABLE 70 JAPAN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 85

TABLE 71 JAPAN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86

TABLE 72 JAPAN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 86

TABLE 73 JAPAN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 87

TABLE 74 CHINA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 87

TABLE 75 CHINA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88

TABLE 76 CHINA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 88

TABLE 77 CHINA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 89

TABLE 78 INDIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 89

TABLE 79 INDIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 90

TABLE 80 INDIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 90

TABLE 81 INDIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 91

TABLE 82 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 91

TABLE 83 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92

TABLE 84 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

2020-2027 (USD MILLION) 92

TABLE 85 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 93

TABLE 86 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 93

TABLE 87 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94

TABLE 88 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 94

TABLE 89 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 95

TABLE 90 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 95

TABLE 91 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 96

TABLE 92 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

2020-2027 (USD MILLION) 96

TABLE 93 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 97

TABLE 94 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE,

2020-2027 (USD MILLION) 97

TABLE 95 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98

TABLE 96 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

2020-2027 (USD MILLION) 98

TABLE 97 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 99

16 List Of Figures

FIGURE 1 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 12

FIGURE 2 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY APPLICATIONS, 2020 (%) 13

FIGURE 3 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 (%) 14

FIGURE 4 MARKET STRUCTURE 16

FIGURE 5 RESEARCH METHODOLOGY 17

FIGURE 6 FORECAST MODEL 21

FIGURE 7 PORTERS FIVE FORCES MODEL 32

FIGURE 8 VALUE CHAIN: TISSUE MICROARRAY 34

FIGURE 9 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 41

FIGURE 10 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 44

FIGURE 11 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020 & 2027 (USD MILLION) 49

FIGURE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 51

FIGURE 13 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 55

FIGURE 14 AMERICA EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 57

FIGURE 15 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 67

FIGURE 16 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 83

FIGURE 17 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPETITIVE LANDSCAPE 100

FIGURE 18 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 101